Risk of death from cardiovascular disease following breast cancer: a systematic review

Breast Cancer Research and Treatment

Volumn 164, Issue 3, 2017, Pages 537-555

  Gernaat, S A M ^a   Ho, P J ^b   Rijnberg, N ^c   Emaus, M J ^a   Baak, L M ^d   Hartman, M ^e   Grobbee, D E ^a   Verkooijen, H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Absolute risk; Breast cancer; Cardiovascular disease; Risk factors

Indexed keywords

ADULT; AGE; BLACK PERSON; BODY WEIGHT; BREAST CANCER; CANCER DIAGNOSIS; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; DIET; ETHNIC DIFFERENCE; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MORTALITY RISK; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TIME; AGED; BREAST TUMOR; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMPLICATION; MIDDLE AGED; MORTALITY; RISK FACTOR;

AGED; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 85019215255     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-017-4282-9     Document Type: Review

References (44)

1. Integraal Kankercentrum Nederland Cijfers over kanker. http://cijfersoverkanker.nl/. Accessed 10 Aug 2016
2. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, Forouzanfar MH, Hancock J, Hay RJ, Hunter-Merrill R, Huynh C, Hosgood HD, Johnson CO, Jonas JB, Khubchandani J, Kumar GA, Kutz M, Lan Q, Larson HJ, Liang X, Lim SS, Lopez AD, MacIntyre MF, Marczak L, Marquez N, Mokdad AH, Pinho C, Pourmalek F, Salomon JA, Sanabria JR, Sandar L, Sartorius B, Schwartz SM, Shackelford KA, Shibuya K, Stanaway J, Steiner C, Sun J, Takahashi K, Vollset SE, Vos T, Wagner JA, Wang H, Westerman R, Zeeb H, Zoeckler L, Abd-Allah F, Ahmed MB, Alabed S, Alam NK, Aldhahri SF, Alem G, Alemayohu MA, Ali R, Al-Raddadi R, Amare A, Amoako Y, Artaman A, Asayesh H, Atnafu N, Awasthi A, Saleem HB, Barac A, Bedi N, Bensenor I, Berhane A, Bernabe E, Betsu B, Binagwaho A, Boneya D, Campos-Nonato I, Castaneda-Orjuela C, Catala-Lopez F, Chiang P, Chibueze C, Chitheer A, Choi JY, Cowie B, Damtew S, das Neves J, Dey S, Dharmaratne S, Dhillon P, Ding E, Driscoll T, Ekwueme D, Endries AY, Farvid M, Farzadfar F, Fernandes J, Fischer F, G/Hiwot TT, Gebru A, Gopalani S, Hailu A, Horino M, Horita N, Husseini A, Huybrechts I, Inoue M, Islami F, Jakovljevic M, James S, Javanbakht M, Jee SH, Kasaeian A, Kedir MS, Khader YS, Khang YH, Kim D, Leigh J, Linn S, Lunevicius R, El Razek HM, Malekzadeh R, Malta DC, Marcenes W, Markos D, Melaku YA, Meles KG, Mendoza W, Mengiste DT, Meretoja TJ, Miller TR, Mohammad KA, Mohammadi A, Mohammed S, Moradi-Lakeh M, Nagel G, Nand D, Le Nguyen Q, Nolte S, Ogbo FA, Oladimeji KE, Oren E, Pa M, Park EK, Pereira DM, Plass D, Qorbani M, Radfar A, Rafay A, Rahman M, Rana SM, Soreide K, Satpathy M, Sawhney M, Sepanlou SG, Shaikh MA, She J, Shiue I, Shore HR, Shrime MG, So S, Soneji S, Stathopoulou V, Stroumpoulis K, Sufiyan MB, Sykes BL, Tabares-Seisdedos R, Tadese F, Tedla BA, Tessema GA, Thakur JS, Tran BX, Ukwaja KN, Uzochukwu BS, Vlassov VV, Weiderpass E, Wubshet Terefe M, Yebyo HG, Yimam HH, Yonemoto N, Younis MZ, Yu C, Zaidi Z, Zaki ME, Zenebe ZM, Murray CJ, Naghavi M (2016) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. doi: 10.1001/jamaoncol.2016.5688
3. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784–1792
4. Nakano M, Fujisue M, Tashima R, Okumura Y, Nishiyama Y, Ohsako T, Toyozumi Y, Arima N, Nishimura R (2015) Survival time according to the year of recurrence and subtype in recurrent breast cancer. Breast 24:588–593. doi:10.1016/j.breast.2015.06.003
5. Riihimaki M, Thomsen H, Brandt A, Sundquist J, Hemminki K (2012) Death causes in breast cancer patients. Ann Oncol 23:604–610. doi:10.1093/annonc/mdr160
6. Berkman A, Cole BF, Ades PA, Dickey S, Higgins ST, Trentham-Dietz A, Sprague BL, Lakoski SG (2014) Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat 148:407–413. doi:10.1007/s10549-014-3168-3
7. Taunk NK, Haffty BG, Kostis JB, Goyal S (2015) Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol 5:39. doi:10.3389/fonc.2015.00039
8. Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD (2016) Cardiovascular disease mortality among breast cancer survivors. Epidemiology 27:6–13. doi:10.1097/EDE.0000000000000394
9. Bird BR, Swain SM (2008) Cardiac toxicity in breast cancer survivors: review of potential cardiac problems. Clin Cancer Res 14:14–24. doi:10.1158/1078-0432.CCR-07-1033
10. Borger JH, Hooning MJ, Boersma LJ, Snijders-Keilholz A, Aleman BM, Lintzen E, van Brussel S, van der Toorn PP, Alwhouhayb M, van Leeuwen FE (2007) Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume. Int J Radiat Oncol Biol Phys 69:1131–1138
11. McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson NO, Bennet AM, Fornander T, Gigante B, Jensen MB, Peto R, Rahimi K, Taylor CW, Ewertz M (2011) Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 100:167–175. doi:10.1016/j.radonc.2011.06.016
12. Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25:3808–3815
13. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catala-Lopez F, Gotzsche PC, Dickersin K, Boutron I, Altman DG, Moher D (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162:777–784. doi:10.7326/M14-2385
14. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
15. Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA (2009) Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomark Prev 18:1403–1409. doi:10.1158/1055-9965.EPI-08-1094
16. McCullough ML, Gapstur SM, Shah R, Campbell PT, Wang Y, Doyle C, Gaudet MM (2016) Pre- and postdiagnostic diet in relation to mortality among breast cancer survivors in the CPS-II Nutrition Cohort. Cancer Causes Control. doi:10.1007/s10552-016-0802-x
17. Solanki PA, Ko NY, Qato DM, Calip GS (2016) Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991–2011. Springerplus. doi: 10.1186/s40064-016-1726-3
18. Colzani E, Liljegren A, Johansson AL, Adolfsson J, Hellborg H, Hall PF, Czene K (2011) Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics. J Clin Oncol 29:4014–4021. doi:10.1200/JCO.2010.32.6462
19. Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP (2011) Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomarkers Prev 20:2120–2126. doi:10.1158/1055-9965.EPI-11-0348
20. Bouchardy C, Rapiti E, Usel M, Majno SB, Vlastos G, Benhamou S, Miralbell R, Neyroud-Caspar I, Verkooijen HM, Vinh-Hung V (2010) Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors. Ann Oncol 21:459–465. doi:10.1093/annonc/mdp341
21. Merzenich H, Bartkowiak D, Schmidberger H, Schmidt M, Schwentner L, Wiegel T, Woeckel A, Wollschlager D, Blettner M (2017) 3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study). Breast Cancer Res Treat 161:143–152. doi:10.1007/s10549-016-4042-2
22. Veal CT, Hart V, Lakoski SG, Hampton JM, Gangnon RE, Newcomb PA, Higgins ST, Trentham-Dietz A, Sprague BL (2017) Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ. J Cancer Surviv. doi:10.1007/s11764-016-0590-z
23. Darby SC, McGale P, Taylor CW, Peto R (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557–565
24. Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419–424.
25. Hooning MJ, Aleman BM, van Rosmalen AJ, Kuenen MA, Klijn JG, van Leeuwen FE (2006) Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study. Int J Radiat Oncol Biol Phys 64:1081–1091.
26. Haque W, Verma V, Haque A, Butler EB, Teh BS (2017) Trends in cardiac mortality in women with ductal carcinoma in situ. Breast Cancer Res Treat 161:345–351. doi:10.1007/s10549-016-4045-z
27. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K, Gansler T, American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62:30–67. doi:10.3322/caac.20140
28. Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, Hamilton AS, Oakley-Girvan I, Keel G, Aziz NM (2013) Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 7:253–261. doi:10.1007/s11764-013-0267-9
29. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand JB, Ewer M, Fabian C, Hudson M, Jessup M, Jones LW, Ky B, Mayer EL, Moslehi J, Oeffinger K, Ray K, Ruddy K, Lenihan D (2017) Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 35:893–911. doi:10.1200/JCO.2016.70.5400
30. EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:2127–2135. doi:10.1016/S0140-6736(14)60488-8
31. Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, Zeller M, Rochette L, Cottin Y, Vergely C (2016) Obesity as a risk factor for anthracyclines and trastuzumab cardiotoxicity in breast cancer: a systematic review and meta-analysis. J Clin Oncol 34:3157–3165
32. Vejpongsa P, Yeh ET (2014) Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. J Am Coll Cardiol 64:938–945. doi:10.1016/j.jacc.2014.06.1167
33. Fan J, Song Y, Chen Y, Hui R, Zhang W (2013) Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol 168:4761–4768. doi:10.1016/j.ijcard.2013.07.230
34. Ringback Weitoft G, Eliasson M, Rosen M (2008) Underweight, overweight and obesity as risk factors for mortality and hospitalization. Scand J Public Health 36:169–176. doi:10.1177/1403494807085080
35. Wu CY, Chou YC, Huang N, Chou YJ, Hu HY, Li CP (2014) Association of body mass index with all-cause and cardiovascular disease mortality in the elderly. PLoS ONE 9:e102589. doi:10.1371/journal.pone.0102589
36. D’Agostino RBS, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743–753. doi:10.1161/CIRCULATIONAHA.107.699579
37. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, Peto R, Baum M, Fisher B, Host H (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447–453. doi:10.1200/JCO.1994.12.3.447
38. Darby SC, Bronnum D, Correa C, Ewertz M, Gagliardi G, Gigante B, McGale P, Nisbet A, Taylor C, Hall P (2010) A dose-response relationship for the incidence of radiation-related heart disease. Int J Radiat Oncol Biol Phys 78:S49–S50
39. Valina-Toth AL, Zavodnik T, Seicean S, Plana J, Marwick T (2013) African american race is a correlate of heart failure in breast cancer survivors: a study of 26,347 women identified with breast cancer from 1973 to 2007. J Am Coll Cardiol 61:E580
40. Budoff MJ, Nasir K, Mao S, Tseng PH, Chau A, Liu ST, Flores F, Blumenthal RS (2006) Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis 187:343–350
41. Sasayama S (2008) Heart disease in Asia. Circulation 118:2669–2671. doi:10.1161/CIRCULATIONAHA.108.837054
42. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294:1765–1772
43. Gernaat SA, Isgum I, de Vos BD, Takx RA, Young-Afat DA, Rijnberg N, Grobbee DE, van der Graaf Y, de Jong PA, Leiner T, van den Bongard DH, Pignol JP, Verkooijen HM (2016) Automatic coronary artery calcium scoring on radiotherapy planning CT scans of breast cancer patients: reproducibility and association with traditional cardiovascular risk factors. PLoS ONE 11:e0167925. doi:10.1371/journal.pone.0167925
44. Maas AH, Ottevanger N, Atsma F, Cramer MJ, Leiner T, Poortmans P (2016) Cardiovascular surveillance in breast cancer treatment: a more individualized approach is needed. Maturitas 89:58–62. doi:10.1016/j.maturitas.2016.04.015